ORIC Pharmaceuticals, Inc.
ORICNASDAQ
Healthcare
Biotechnology
$8.90
+1.43(19.1%)
52W $4.26 – $14.41
Quick:
8-K
Mar 31, 2026 (6 days ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Feb 23, 2026 (1 months ago)Current Report
Material event disclosure
Event materiality and market reaction
10-K
Feb 23, 2026 (1 months ago)Annual Report
Full-year financial statements and risk factors
YoY revenue/margin trends, new risk disclosures
8-K
Feb 23, 2026 (1 months ago)Current Report
Material event disclosure
Event materiality and market reaction
SCHEDULE 13G/A
Feb 17, 2026 (1 months ago)Beneficial Ownership (Amendment)
Large shareholder position disclosure
Ownership threshold, passive vs active
SCHEDULE 13G
Jan 21, 2026 (2 months ago)Beneficial Ownership
Large shareholder position disclosure
Ownership threshold, passive vs active
8-K
Dec 8, 2025 (3 months ago)Current Report
Material event disclosure
Event materiality and market reaction
SCHEDULE 13G/A
Nov 17, 2025 (4 months ago)Beneficial Ownership (Amendment)
Large shareholder position disclosure
Ownership threshold, passive vs active
SCHEDULE 13G/A
Nov 13, 2025 (4 months ago)Beneficial Ownership (Amendment)
Large shareholder position disclosure
Ownership threshold, passive vs active
10-Q
Nov 13, 2025 (4 months ago)Quarterly Report
Quarterly financial update
Sequential growth, guidance changes
8-K
Nov 13, 2025 (4 months ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Nov 13, 2025 (4 months ago)Current Report
Material event disclosure
Event materiality and market reaction
SCHEDULE 13G/A
Aug 14, 2025 (7 months ago)Beneficial Ownership (Amendment)
Large shareholder position disclosure
Ownership threshold, passive vs active
SCHEDULE 13D/A
Aug 14, 2025 (7 months ago)SCHEDULE 13D/A (Amendment)
SEC filing disclosure
Filing details and context
SCHEDULE 13G/A
Aug 14, 2025 (7 months ago)Beneficial Ownership (Amendment)
Large shareholder position disclosure
Ownership threshold, passive vs active
10-Q
Aug 12, 2025 (7 months ago)Quarterly Report
Quarterly financial update
Sequential growth, guidance changes
8-K
Aug 12, 2025 (7 months ago)Current Report
Material event disclosure
Event materiality and market reaction
SCHEDULE 13G
Aug 5, 2025 (8 months ago)Beneficial Ownership
Large shareholder position disclosure
Ownership threshold, passive vs active
SCHEDULE 13G/A
Jul 17, 2025 (8 months ago)Beneficial Ownership (Amendment)
Large shareholder position disclosure
Ownership threshold, passive vs active
8-K
Jun 13, 2025 (9 months ago)Current Report
Material event disclosure
Event materiality and market reaction